Clinical Trials Browser

Multiple Myeloma, Renal Insufficiency

NCT06623630 2026-03-11

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Phase 1 Recruiting

16 enrolled

Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT07029503 2026-02-24

SCARF-1

Phase 2 Recruiting

40 enrolled

Lymphoid

Heart Failure, Lymphoma, Follicular, Renal Insufficiency, Chronic, Renal Insufficiency

NCT04240054 2026-01-28

VICD

Phase 2 Recruiting

41 enrolled

Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT05992363 2025-07-24

TSTENT

Phase NA Recruiting

106 enrolled

Bites and Stings, Hydronephrosis, Neoplasms, Ureteral Obstruction, Renal Insufficiency

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

90 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT04823923 2025-02-12

IREKI

Phase NA Recruiting

60 enrolled

Genitourinary

Kidney Neoplasms, Renal Insufficiency

NCT06337942 2025-02-12

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Phase NA Recruiting

5 enrolled

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Renal Insufficiency

NCT05797649 2024-11-13

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Recruiting

120 enrolled

Thoracic

Edema, Fibrosis, Heart Failure, Infections, Neoplasms, Pleural Effusion, Tuberculosis, Hypoalbuminemia, Renal Insufficiency

Clinical Trials

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

SCARF-1

VICD

TSTENT

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

IREKI

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)